(Q42255851)

19 October 2017

title

Nifedipine serum concentration; effects upon blood pressure and heart rate in normotensive volunteers (English)

1 reference

19 October 2017

1 reference

T Nakashima

1

1 reference

19 October 2017

M Inoki

series ordinal

2

1 reference

19 October 2017

Y Nakanishi

series ordinal

3

1 reference

19 October 2017

publication date

1 January 1984

1 reference

European Journal of Drug Metabolism and Pharmacokinetics

19 October 2017

published in

1 reference

19 October 2017

volume

9

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

73-78

1 reference

Acute and chronic effects of nifedipine in arterial hypertension

19 October 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03189607

Treatment of hypertension with nifedipine, a calcium antagonistic agent

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03189607

Fluorometric determination of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester and its main metabolite

21 January 2018

1 reference

12 December 2020

Per cent absorbed time plots derived from blood level and/or urinary excretion data

1 reference

12 December 2020

Structural analysis of the renal excretion products of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester

1 reference

12 December 2020

Identification of nifedipine metabolites and their determination by gas chromatography

1 reference

12 December 2020

Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension

1 reference

12 December 2020

Comparison of Acute Effects of Nifedipine in Normotensive and Hypertensive Man

1 reference

12 December 2020

Dihydropyridines, a new group of strongly effective coronary therapeutic agents

1 reference

12 December 2020

Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection

1 reference

12 December 2020

Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)

1 reference

12 December 2020

Animal experiments on pharmacokinetic and biotransformation of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester

1 reference

12 December 2020

Quantitative determination of nifedipine in human plasma by selected ion monitoring

1 reference

12 December 2020

Determination of a new cerebral vasodilator 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93) in plasma by electron capture gas chromatography

1 reference

12 December 2020

Clinical study on the pharmacokinetics of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03189607

1 reference

Dimensions Publication ID

19 October 2017

1017002907

0 references

1 reference